X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with FDC LTD. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE FDC LTD. SUVEN LIFE/
FDC LTD.
 
P/E (TTM) x 19.3 29.0 66.6% View Chart
P/BV x 3.6 6.0 59.3% View Chart
Dividend Yield % 1.0 0.8 133.6%  

Financials

 SUVEN LIFE   FDC LTD.
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
FDC LTD.
Mar-14
SUVEN LIFE/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs339144 235.9%   
Low Rs14479 182.8%   
Sales per share (Unadj.) Rs39.247.6 82.5%  
Earnings per share (Unadj.) Rs7.57.6 98.1%  
Cash flow per share (Unadj.) Rs8.89.0 97.4%  
Dividends per share (Unadj.) Rs2.002.25 88.9%  
Dividend yield (eoy) %0.82.0 41.0%  
Book value per share (Unadj.) Rs49.047.5 103.1%  
Shares outstanding (eoy) m127.28177.83 71.6%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x6.22.3 263.0%   
Avg P/E ratio x32.414.6 221.3%  
P/CF ratio (eoy) x27.512.3 222.8%  
Price / Book Value ratio x4.92.3 210.6%  
Dividend payout %26.829.6 90.6%   
Avg Mkt Cap Rs m30,73219,784 155.3%   
No. of employees `0001.0NA-   
Total wages/salary Rs m4161,221 34.1%   
Avg. sales/employee Rs Th5,236.1NM-  
Avg. wages/employee Rs Th436.5NM-  
Avg. net profit/employee Rs Th995.5NM-  
INCOME DATA
Net Sales Rs m4,9958,459 59.1%  
Other income Rs m194394 49.2%   
Total revenues Rs m5,1898,852 58.6%   
Gross profit Rs m1,2332,070 59.5%  
Depreciation Rs m167249 67.1%   
Interest Rs m5431 174.8%   
Profit before tax Rs m1,2052,184 55.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m255606 42.1%   
Profit after tax Rs m9501,353 70.2%  
Gross profit margin %24.724.5 100.8%  
Effective tax rate %21.227.7 76.3%   
Net profit margin %19.016.0 118.8%  
BALANCE SHEET DATA
Current assets Rs m4,9864,355 114.5%   
Current liabilities Rs m1,0421,792 58.2%   
Net working cap to sales %79.030.3 260.5%  
Current ratio x4.82.4 196.8%  
Inventory Days Days6144 137.2%  
Debtors Days Days3925 158.7%  
Net fixed assets Rs m3,1263,025 103.3%   
Share capital Rs m127179 71.3%   
"Free" reserves Rs m3,7178,243 45.1%   
Net worth Rs m6,2368,453 73.8%   
Long term debt Rs m43211 4,040.2%   
Total assets Rs m8,07910,557 76.5%  
Interest coverage x23.271.4 32.5%   
Debt to equity ratio x0.10 5,476.2%  
Sales to assets ratio x0.60.8 77.2%   
Return on assets %12.413.1 94.8%  
Return on equity %15.216.0 95.1%  
Return on capital %18.923.5 80.3%  
Exports to sales %87.513.3 657.4%   
Imports to sales %12.23.3 365.7%   
Exports (fob) Rs m4,3711,126 388.2%   
Imports (cif) Rs m611283 216.0%   
Fx inflow Rs m4,6661,146 407.2%   
Fx outflow Rs m942355 265.2%   
Net fx Rs m3,724791 471.0%   
CASH FLOW
From Operations Rs m9221,485 62.1%  
From Investments Rs m-619-620 100.0%  
From Financial Activity Rs m-698-753 92.8%  
Net Cashflow Rs m-396113 -350.8%  

Share Holding

Indian Promoters % 63.4 68.9 92.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.7 -  
FIIs % 0.0 7.5 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 19.0 192.1%  
Shareholders   37,287 23,730 157.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   ASTRAZENECA PHARMA  DR. DATSONS LABS  ELDER PHARMA  GSK PHARMA  PANACEA BIOTECH  

Compare SUVEN LIFE With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Start to the Week; PSU & Metal Stocks Fall(Closing)

Indian share markets continued to witness selling pressure in the afternoon session as benchmark Sensex slipped below the 34,000-mark.

Related Views on News

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

More Views on News

Most Popular

Here's What You Should Do in this Market Crash(The 5 Minute Wrapup)

Feb 6, 2018

The market correction has provided a golden opportunity to buy five high-quality safe stocks.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

When Small is Not Always Beautiful(Chart Of The Day)

Feb 6, 2018

Big companies enjoying tax deductions and exemptions have an edge over the small companies.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Feb 19, 2018 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS